trending Market Intelligence /marketintelligence/en/news-insights/trending/bCU4RqQCZEUTU67acTHLRQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Mylan launches generic version of EpiPen

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Mylan launches generic version of EpiPen

Mylan NV launched an authorized generic for its EpiPen Auto-Injector at $300 for a pack of two injections.

The generic product has the same drug formulation and device functionality as EpiPen and will reach retail pharmacies in the week of Dec. 19.